Showing results (1-10 of 49) with videos related to
Sort By:
Pageof 5
Frontiers in Oncology|August 21, 2024
Integrating electromagnetic cancer stress with immunotherapy: a therapeutic paradigmMark M FusterProgress in Molecular Biology and Translational Science|September 3, 2010
Endothelial heparan sulfate in angiogenesisMark M Fuster, Lianchun WangNature Reviews. Cancer|August 3, 2005
The sweet and sour of cancer: glycans as novel therapeutic targetsMark M Fuster, Jeffrey D EskoThe Journal of Biological Chemistry|October 27, 2010
Heparan sulfate regulates VEGF165- and VEGF121-mediated vascular hyperpermeabilityDing Xu, Mark M Fuster, Roger Lawrence, et al.The Journal of Biological Chemistry|April 11, 2003
Expression patterns of alpha 2,3-sialyltransferases and alpha 1,3-fucosyltransferases determine the mode of sialyl Lewis X inhibition by disaccharide decoysJillian R Brown, Mark M Fuster, Thomas Whisenant, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 23, 2020
Effects of curative-intent lung cancer therapy on functional exercise capacity and patient-reported outcomesDuc Ha, Andrew L Ries, Scott M Lippman, et al.Cancer Research|June 5, 2003
A disaccharide precursor of sialyl Lewis X inhibits metastatic potential of tumor cellsMark M Fuster, Jillian R Brown, Lianchun Wang, et al.Neoplasia (New York, N.Y.)|October 29, 2021
Targeting glycan sulfation in a CD11c+ myeloid population inhibits early KRAS-mutant lung neoplasiaSo Young Kim, Scott C Johns, Purva Gupta, et al.Frontiers in Oncology|January 2, 2026
The challenge of cytotoxic T cell responses in carcinoma with a focus on lung carcinomaAditya Dash, Afsheen Banisadr, Donivian Al Dikka, et al.Respiratory Physiology & Neurobiology|August 4, 2019
Heart rate variability and heart rate recovery in lung cancer survivors eligible for long-term cureDuc Ha, Atul Malhotra, Andrew L Ries, et al.Pageof 5